These results show that BCR-ABL-expressing leukemic stem cells depend to a greater extent on CD44 for homing and engraftment than do normal HSCs, and argue that CD44 blockade may be beneficial in autologous transplantation in CML [37]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.